Top Biotechnology companies in Netherlands by Total Assets

This ranking features the top 6 Biotechnology companies in Netherlands ranked by Total Assets, totaling a Total Assets of USD 8.15 B, for July 27, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Netherlands has the highest Total Assets ?

The Biotechnology company in Netherlands with the highest Total Assets is Qiagen N.V. (NYSE: QGEN) at USD 5.69 B.

Which Biotechnology company in Netherlands has the lowest Total Assets ?

The Biotechnology company in Netherlands with the lowest Total Assets is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 80.83 M.

What are the top 10 Biotechnology companies in Netherlands by Total Assets ?

The top 10 Biotechnology companies in Netherlands by Total Assets are Qiagen N.V., NewAmsterdam Pharma Company N.V., Merus N.V., uniQure N.V., ProQR Therapeutics N.V. and LAVA Therapeutics N.V..

What are the bottom 10 Biotechnology companies in Netherlands by Total Assets ?

The bottom 10 Biotechnology companies in Netherlands by Total Assets are LAVA Therapeutics N.V., ProQR Therapeutics N.V., uniQure N.V., Merus N.V., NewAmsterdam Pharma Company N.V. and Qiagen N.V..